Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
[Mucoviscidosis].

Fel'dsher i akusherka

Rachinskiĭ SV, Kapranov NI.
PMID: 3356251
Feldsher Akush. 1988 Jan;53(1):25-8.

No abstract available.

[Treatment and prevention of chronic circulatory failure].

Fel'dsher i akusherka

Groshenkova VP.
PMID: 3691849
Feldsher Akush. 1987 Sep;52(9):12-5.

No abstract available.

Head and neck oncology: what the past decade has taught us.

Expert review of anticancer therapy

Bernier J.
PMID: 17020448
Expert Rev Anticancer Ther. 2006 Sep;6(9):1133-6. doi: 10.1586/14737140.6.9.1133.

No abstract available.

Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.

The oncologist

Wang Y, Pandey M, Ballo MT.
PMID: 31444292
Oncologist. 2019 Dec;24(12):e1426-e1436. doi: 10.1634/theoncologist.2017-0603. Epub 2019 Aug 23.

Tumor-treating fields (TTFields) are a noninvasive antimitotic cancer treatment consisting of low-intensity alternating electric fields delivered to the tumor or tumor bed via externally applied transducer arrays. In multiple in vitro and in vivo cancer cell lines, TTFields therapy...

New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?.

Cells

Aurilio G, Cimadamore A, Santoni M, Nolè F, Scarpelli M, Massari F, Lopez-Beltran A, Cheng L, Montironi R.
PMID: 32580469
Cells. 2020 Jun 22;9(6). doi: 10.3390/cells9061522.

Medical treatment for metastatic castration-resistant prostate cancer (mCRPC) patients has progressively been evolving from a nonspecific clinical approach to genomics-oriented therapies. The scientific community is in fact increasingly focusing on developing DNA damage repair (DDR) defect-driven novel molecules, both...

Single-handed vampire facial: Combining microneedling with platelet-rich plasma for single-hand use.

Journal of the American Academy of Dermatology

Pathania V, Oberoi B, Shankar P, Bhatt S.
PMID: 31408682
J Am Acad Dermatol. 2021 Feb;84(2):e77-e78. doi: 10.1016/j.jaad.2019.08.013. Epub 2019 Aug 10.

No abstract available.

Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference.

Cancer gene therapy

Dyer A, Baugh R, Chia SL, Frost S, Iris, Jacobus EJ, Khalique H, Pokrovska TD, Scott EM, Taverner WK, Seymour LW, Lei J.
PMID: 30177818
Cancer Gene Ther. 2019 Mar;26(3):59-73. doi: 10.1038/s41417-018-0042-1. Epub 2018 Sep 04.

The 11th International Oncolytic Virus Conference (IOVC) was held from April 9-12, 2018 in Oxford, UK. This is part of the high-profile academic-led series of meetings that was started back in 2002 by Steve Russell and John Bell, with...

Emerging Multimodality Approaches to Treat Localized Esophageal Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN

Kelly RJ.
PMID: 31390584
J Natl Compr Canc Netw. 2019 Aug 01;17(8):1009-1014. doi: 10.6004/jnccn.2019.7337.

Esophageal cancer has a poor prognosis, with 5-year survival rates ranging from 20% to 35% in the nonmetastatic setting. Despite advances in surgical techniques and optimization of chemoradiotherapy regimens, overall survival benefits have been incremental at best. Esophageal cancer...

Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors.

Viruses

Rajani KR, Vile RG.
PMID: 26580645
Viruses. 2015 Nov 13;7(11):5889-901. doi: 10.3390/v7112914.

Oncolytic viruses represent a diverse class of replication competent viruses that curtail tumor growth. These viruses, through their natural ability or through genetic modifications, can selectively replicate within tumor cells and induce cell death while leaving normal cells intact....

Systematic review of combinations of targeted or immunotherapy in advanced solid tumors.

Journal for immunotherapy of cancer

Tan AC, Bagley SJ, Wen PY, Lim M, Platten M, Colman H, Ashley DM, Wick W, Chang SM, Galanis E, Mansouri A, Khagi S, Mehta MP, Heimberger AB, Puduvalli VK, Reardon DA, Sahebjam S, Simes J, Antonia SJ, Berry D, Khasraw M.
PMID: 34215688
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002459.

With rapid advances in our understanding of cancer, there is an expanding number of potential novel combination therapies, including novel-novel combinations. Identifying which combinations are appropriate and in which subpopulations are among the most difficult questions in medical research....

Showing 1 to 10 of 10 entries